Skip to main content
OpenTrials

Clinical trial condition

Recurrent Glioblastoma

Explore clinical trials studying Recurrent Glioblastoma. Study availability and eligibility vary by location and protocol.

111 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Glioblastoma trial results

Active, Not Recruiting

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT03115333

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Cediranib Maleate and Olaparib Compared to Bevacizumab in Treating Patients With Recurrent Glioblastoma

NCT02974621

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center-Fairfield Fairfield, Connecticut, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

NCT04323046

Conditions
Astrocytoma, Glioblastoma, Glioma, +12 more
Locations
  • University of Alabama at Birmingham, Children's of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma

NCT04729959

Conditions
Astrocytoma, Diffuse Astrocytoma, IDH-Wildtype, Glioblastoma, +9 more
Locations
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
View all 110 locations
View Trial Details

Related conditions